About: Michael Bonney

Facets (new session)
Description
Metadata
Settings
- Rule:
- Inverse Functional Properties:
- "Same As":

About: Michael Bonney Goto Sponge NotDistinct Permalink

An Entity of Type : schema:Person, within Data Space : dbpedia.org associated with source document(s)
QRcode icon

http://dbpedia.org/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FMichael_Bonney

Michael "Mike" Weston Bonney is an American businessman and former pharmaceutical executive. Bonney was the president and chief executive officer of Cubist Pharmaceuticals, from 2003 until his retirement in 2014 coinciding with the company being acquired by Merck & Co. for $9.5 billion. Bonney serves as an advisor to former Prime Minister David Cameron's Commission on Antimicrobial Resistance (AMR).

Attributes	Values
rdf:type	Thing foaf:Person person dul:NaturalPerson Eukaryote Person Human Animal animal eukaryote species schema:Person
rdfs:label	Michael Bonney (en)
rdfs:comment	Michael "Mike" Weston Bonney is an American businessman and former pharmaceutical executive. Bonney was the president and chief executive officer of Cubist Pharmaceuticals, from 2003 until his retirement in 2014 coinciding with the company being acquired by Merck & Co. for $9.5 billion. Bonney serves as an advisor to former Prime Minister David Cameron's Commission on Antimicrobial Resistance (AMR). (en)
foaf:name	Michael Bonney (en)
name	Michael Bonney (en)
foaf:depiction
dcterms:subject	Living people Year of birth missing (living people) American chief executives American chief operating officers Bates College alumni
Wikipage page ID	50620768 (xsd:integer)
Wikipage revision ID	1087465051 (xsd:integer)
Link from a Wikipage to another Wikipage	Bates College Biogen Biomedicine Boston David Cameron List of largest selling pharmaceutical products Living people Year of birth missing (living people) Sales Chief executive officer Chief operating officer Greater Boston Multiple sclerosis Antibiotic Lewiston, Maine Board of directors Shire (pharmaceutical company) Startup company Clinical trial Fundraising Pharmaceutical industry Marketing American chief executives American chief operating officers Celgene Whitehead Institute List of Bates College people Alnylam Pharmaceuticals Cubist Pharmaceuticals Daptomycin Economics Food and Drug Administration Angel investor President (corporate title) The Boston Globe Bates College alumni MarketWatch Market Watch Business executive Injection (medicine) Interferon beta-1a Merck & Co. New England Cable News Optimer Pharmaceuticals Rare (conservation organization) Trius Therapeutics Third Rock Ventures Artium Baccalaureus
sameAs	Michael Bonney Michael Bonney Michael Bonney
dbp:wikiPageUsesTemplate	dbt:Infobox_person dbt:Reflist dbt:Short_description
thumbnail	wiki-commons:Special:FilePath/Michael_Bonney,_May-2014.gif?width=300
alma mater	Bates College
birth name	Michael Weston Bonney (en)
caption	Bonney as chief executive of Cubist Pharmaceuticals (en)
nationality	American (en)
occupation	(en) COO of Cubist Pharmaceuticals (en) President & CEO of Cubist Pharmaceuticals (en)
spouse	Allison Grott Bonney (en)
years active	1984 (xsd:integer)
has abstract	Michael "Mike" Weston Bonney is an American businessman and former pharmaceutical executive. Bonney was the president and chief executive officer of Cubist Pharmaceuticals, from 2003 until his retirement in 2014 coinciding with the company being acquired by Merck & Co. for $9.5 billion. Bonney, a native of the Greater Boston area, graduated from Bates College before entering the pharmaceutical industry. He was hired by Biogen in 1995 eventually becoming the company's vice president for Sales and Marketing. During his tenure at the company he developed Avonex, which was according to MarketWatch, one of the most successful drugs in biotechnology history. He was appointed the chief operating officer of Cubist Pharmaceuticals in 2003 and served in the position for one year before becoming chief executive. His tenure as CEO saw mixed profit levels, criticism, and increased market volatility as well as the development and release of Cubicin, the most profitable launch of an antibiotic in the history of the United States. Bonney serves as an advisor to former Prime Minister David Cameron's Commission on Antimicrobial Resistance (AMR). (en)
boards	Bates College (en) (en) Whitehead Institute (en) Alnylam Pharmaceuticals (en) Cubist Pharmaceuticals (en) Celgene Limited (en) Manufacturers of America (en)
employer	* Biogen * Cubist Pharmaceuticals (en)
board	Bates College Celgene Whitehead Institute

Faceted Search & Find service v1.17_git139 as of Feb 29 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (62 GB total memory, 56 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software